在风湿性关节炎相关的间歇性肺部疾病中,MUC5B促销器变异和生存率
Jacob Klein1, Austin Wheeler1, Joshua F Baker2
1Division of Rheumatology & Immunology, VA Nebraska Western Iowa Health Care System & University of Nebraska Medical Center, Omaha, NE.
Rheumatology (Oxford, England)
|November 6, 2024
概括
虽然MUC5B rs35705950促进体变异与风湿性关节炎相关的间歇性肺病 (RA-ILD) 风险有关,但它无法预测RA-ILD患者的存活率. 需要进一步的研究,以找到其他预后因素,以更好地管理疾病.
科学领域:
- 遗传学 是一个遗传学.
- 肺部病理学 肺部病理学
- 类风湿病学 类风湿病学
背景情况:
- 风湿性关节炎相关的间歇性肺病 (RA-ILD) 是致病率和死亡率的重要原因.
- MUC5B rs35705950促进子变体是发展ILD的已知危险因素,包括RA-ILD.
研究的目的:
- 研究RA-ILD患者MUC5B rs35705950促进体变异与生存结果之间的关联.
- 为了确定这种基因变异是否可以作为RA-ILD患者的预后标志物.
主要方法:
- 分析了来自退伍军人事务风湿关节炎 (VARA) 登记册的263名RA-ILD患者的队列.
- 对MUC5B rs35705950促销物变体进行基因定型,并跟踪患者的存活率和死亡原因.
- 使用考克斯回归模型来评估MUC5B变异与生存之间的关联,并对混因素进行调整.
主要成果:
- 在RA-ILD队列中的33.5%中存在MUC5B促进体变异.
- 患有MUC5B变异的患者和没有MUC5B变异的患者之间的死亡率相似.
- MUC5B变异与整体存活率,依据ILD模式分层的存活率或死亡原因没有显著关联.
结论:
- 在RA-ILD患者中,MUC5B rs35705950促进体变异并不是生存的预测指标.
- 需要额外的遗传和非遗传因素来确定RA-ILD的预后标志物.
- 进一步的研究对于改善RA-ILD的临床管理至关重要.
相关概念视频
Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...


